» Articles » PMID: 36697767

Spectrins: Molecular Organizers and Targets of Neurological Disorders

Overview
Specialty Neurology
Date 2023 Jan 25
PMID 36697767
Authors
Affiliations
Soon will be listed here.
Abstract

Spectrins are cytoskeletal proteins that are expressed ubiquitously in the mammalian nervous system. Pathogenic variants in SPTAN1, SPTBN1, SPTBN2 and SPTBN4, four of the six genes encoding neuronal spectrins, cause neurological disorders. Despite their structural similarity and shared role as molecular organizers at the cell membrane, spectrins vary in expression, subcellular localization and specialization in neurons, and this variation partly underlies non-overlapping disease presentations across spectrinopathies. Here, we summarize recent progress in discerning the local and long-range organization and diverse functions of neuronal spectrins. We provide an overview of functional studies using mouse models, which, together with growing human genetic and clinical data, are helping to illuminate the aetiology of neurological spectrinopathies. These approaches are all critical on the path to plausible therapeutic solutions.

Citing Articles

Paralemmin-1 controls the nanoarchitecture of the neuronal submembrane cytoskeleton.

Macarron-Palacios V, Hubrich J, do Rego Barros Fernandes Lima M, Metzendorf N, Kneilmann S, Trapp M Sci Adv. 2025; 11(10):eadt3724.

PMID: 40053592 PMC: 11887803. DOI: 10.1126/sciadv.adt3724.


pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of ALS/FTD patients.

Wang H, Xiang J, Yuan C, Veire A, Gendron T, Murray M Proc Natl Acad Sci U S A. 2025; 122(9):e2419818122.

PMID: 39999167 PMC: 11892677. DOI: 10.1073/pnas.2419818122.


Axonal Mechanotransduction Drives Cytoskeletal Responses to Physiological Mechanical Forces.

Swaim G, Glomb O, Xie Y, Emerson C, Li Z, Beaudet D bioRxiv. 2025; .

PMID: 39990487 PMC: 11844441. DOI: 10.1101/2025.02.11.637689.


βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophrenia.

Di Re J, Marini M, Hussain S, Singh A, Venkatesh A, Alshammari M Mol Psychiatry. 2025; .

PMID: 39920295 DOI: 10.1038/s41380-025-02917-1.


QTL mapping provides new insights into emamectin benzoate resistance in salmon lice, Lepeophtheirus salmonis.

Sturm A, Carmona-Antonanzas G, Humble J, Croton C, Boyd S, Mphuti R BMC Genomics. 2024; 25(1):1212.

PMID: 39695954 PMC: 11657612. DOI: 10.1186/s12864-024-11096-2.


References
1.
Rinaldi C, Wood M . Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2017; 14(1):9-21. DOI: 10.1038/nrneurol.2017.148. View

2.
Ohara O, OHara R, Yamakawa H, Nakajima D, Nakayama M . Characterization of a new beta-spectrin gene which is predominantly expressed in brain. Brain Res Mol Brain Res. 1998; 57(2):181-92. DOI: 10.1016/s0169-328x(98)00068-0. View

3.
Lambert S, Bennett V . Postmitotic expression of ankyrinR and beta R-spectrin in discrete neuronal populations of the rat brain. J Neurosci. 1993; 13(9):3725-35. PMC: 6576446. View

4.
Saitsu H, Tohyama J, Kumada T, Egawa K, Hamada K, Okada I . Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet. 2010; 86(6):881-91. PMC: 3032058. DOI: 10.1016/j.ajhg.2010.04.013. View

5.
Papal S, Cortese M, Legendre K, Sorusch N, Dragavon J, Sahly I . The giant spectrin βV couples the molecular motors to phototransduction and Usher syndrome type I proteins along their trafficking route. Hum Mol Genet. 2013; 22(18):3773-88. DOI: 10.1093/hmg/ddt228. View